Pharmaceutical CDMO Services -Global Market Status and Trend Report 2013-2023

Table of Contents

Chapter 1 Overview of Pharmaceutical CDMO Services

• 1.1 Definition of Pharmaceutical CDMO Services in This Report
• 1.2 Commercial Types of Pharmaceutical CDMO Services
  • 1.2.1 Drug Substance Development and Manufacturing
  • 1.2.2 Specialized Services
  • 1.2.3 Lab-based Services
• 1.3 Downstream Application of Pharmaceutical CDMO Services
  • 1.3.1 nnovative Medicine
  • 1.3.2 Patented Drug
  • 1.3.3 Patent Expired Drug
• 1.4 Development History of Pharmaceutical CDMO Services
• 1.5 Market Status and Trend of Pharmaceutical CDMO Services 2013-2023
  • 1.5.1 Global Pharmaceutical CDMO Services Market Status and Trend 2013-2023
  • 1.5.2 Regional Pharmaceutical CDMO Services Market Status and Trend 2013-2023

Chapter 2 Global Market Status and Forecast by Regions

• 2.1 Market Development of Pharmaceutical CDMO Services 2013-2017
• 2.2 Production Market of Pharmaceutical CDMO Services by Regions
  • 2.2.1 Production Volume of Pharmaceutical CDMO Services by Regions
  • 2.2.2 Production Value of Pharmaceutical CDMO Services by Regions
• 2.3 Demand Market of Pharmaceutical CDMO Services by Regions
• 2.4 Production and Demand Status of Pharmaceutical CDMO Services by Regions
  • 2.4.1 Production and Demand Status of Pharmaceutical CDMO Services by Regions 2013-2017
  • 2.4.2 Import and Export Status of Pharmaceutical CDMO Services by Regions 2013-2017

Chapter 3 Global Market Status and Forecast by Types

• 3.1 Production Volume of Pharmaceutical CDMO Services by Types
• 3.2 Production Value of Pharmaceutical CDMO Services by Types
• 3.3 Market Forecast of Pharmaceutical CDMO Services by Types

Chapter 4 Global Market Status and Forecast by Downstream Industry

• 4.1 Demand Volume of Pharmaceutical CDMO Services by Downstream Industry
• 4.2 Market Forecast of Pharmaceutical CDMO Services by Downstream Industry

Chapter 5 Market Driving Factor Analysis of Pharmaceutical CDMO Services

• 5.1 Global Economy Situation and Trend Overview
• 5.2 Pharmaceutical CDMO Services Downstream Industry Situation and Trend Overview

Chapter 6 Pharmaceutical CDMO Services Market Competition Status by Major Manufacturers

• 6.1 Production Volume of Pharmaceutical CDMO Services by Major Manufacturers
• 6.2 Production Value of Pharmaceutical CDMO Services by Major Manufacturers
• 6.3 Basic Information of Pharmaceutical CDMO Services by Major Manufacturers
  • 6.3.1 Headquarters Location and Established Time of Pharmaceutical CDMO Services Major Manufacturer
  • 6.3.2 Employees and Revenue Level of Pharmaceutical CDMO Services Major Manufacturer
• 6.4 Market Competition News and Trend
  • 6.4.1 Merger, Consolidation or Acquisition News
  • 6.4.2 Investment or Disinvestment News
  • 6.4.3 New Product Development and Launch

Chapter 7 Pharmaceutical CDMO Services Major Manufacturers Introduction and Market Data

• 7.1 WuXi AppTec Group
  • 7.1.1 Company profile
  • 7.1.2 Representative Pharmaceutical CDMO Services Product
  • 7.1.3 Pharmaceutical CDMO Services Sales, Revenue, Price and Gross Margin of WuXi AppTec Group
• 7.2 Strides Pharma Science Limited
  • 7.2.1 Company profile
  • 7.2.2 Representative Pharmaceutical CDMO Services Product
  • 7.2.3 Pharmaceutical CDMO Services Sales, Revenue, Price and Gross Margin of Strides Pharma Science Limited
• 7.3 Aenova Group
  • 7.3.1 Company profile
  • 7.3.2 Representative Pharmaceutical CDMO Services Product
  • 7.3.3 Pharmaceutical CDMO Services Sales, Revenue, Price and Gross Margin of Aenova Group
• 7.4 AMRI Global
  • 7.4.1 Company profile
  • 7.4.2 Representative Pharmaceutical CDMO Services Product
  • 7.4.3 Pharmaceutical CDMO Services Sales, Revenue, Price and Gross Margin of AMRI Global
• 7.5 Recipharm AB
  • 7.5.1 Company profile
  • 7.5.2 Representative Pharmaceutical CDMO Services Product
  • 7.5.3 Pharmaceutical CDMO Services Sales, Revenue, Price and Gross Margin of Recipharm AB
• 7.6 Patheon N.V.
  • 7.6.1 Company profile
  • 7.6.2 Representative Pharmaceutical CDMO Services Product
  • 7.6.3 Pharmaceutical CDMO Services Sales, Revenue, Price and Gross Margin of Patheon N.V.
• 7.7 Siegfried Ltd
  • 7.7.1 Company profile
  • 7.7.2 Representative Pharmaceutical CDMO Services Product
  • 7.7.3 Pharmaceutical CDMO Services Sales, Revenue, Price and Gross Margin of Siegfried Ltd
• 7.8 Amatsigroup
  • 7.8.1 Company profile
  • 7.8.2 Representative Pharmaceutical CDMO Services Product
  • 7.8.3 Pharmaceutical CDMO Services Sales, Revenue, Price and Gross Margin of Amatsigroup
• 7.9 Catalent, Inc.
  • 7.9.1 Company profile
  • 7.9.2 Representative Pharmaceutical CDMO Services Product
  • 7.9.3 Pharmaceutical CDMO Services Sales, Revenue, Price and Gross Margin of Catalent, Inc.
• 7.10 Piramal Pharma Solutions
  • 7.10.1 Company profile
  • 7.10.2 Representative Pharmaceutical CDMO Services Product
  • 7.10.3 Pharmaceutical CDMO Services Sales, Revenue, Price and Gross Margin of Piramal Pharma Solutions
• 7.11 Fareva Group
  • 7.11.1 Company profile
  • 7.11.2 Representative Pharmaceutical CDMO Services Product
  • 7.11.3 Pharmaceutical CDMO Services Sales, Revenue, Price and Gross Margin of Fareva Group
• 7.12 FAMAR Health Care Services
  • 7.12.1 Company profile
  • 7.12.2 Representative Pharmaceutical CDMO Services Product
  • 7.12.3 Pharmaceutical CDMO Services Sales, Revenue, Price and Gross Margin of FAMAR Health Care Services

Chapter 8 Upstream and Downstream Market Analysis of Pharmaceutical CDMO Services

• 8.1 Industry Chain of Pharmaceutical CDMO Services
• 8.2 Upstream Market and Representative Companies Analysis
• 8.3 Downstream Market and Representative Companies Analysis

Chapter 9 Cost and Gross Margin Analysis of Pharmaceutical CDMO Services

• 9.1 Cost Structure Analysis of Pharmaceutical CDMO Services
• 9.2 Raw Materials Cost Analysis of Pharmaceutical CDMO Services
• 9.3 Labor Cost Analysis of Pharmaceutical CDMO Services
• 9.4 Manufacturing Expenses Analysis of Pharmaceutical CDMO Services

Chapter 10 Marketing Status Analysis of Pharmaceutical CDMO Services

• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
  • 10.1.3 Marketing Channel Development Trend
• 10.2 Market Positioning
  • 10.2.1 Pricing Strategy
  • 10.2.2 Brand Strategy
  • 10.2.3 Target Client
• 10.3 Distributors/Traders List

Chapter 11 Report Conclusion

Chapter 12 Research Methodology and Reference

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources